Stock Ticker

  • Loading stock data...

Novartis AG (NYSE:NVS) Fires Leading Scientists Over Claims Of Gene Therapy Data Manipulation

The gene therapy division of Novartis AG (NYSE:NVS) will be missing the services of two of the company’s top scientists. Brian Kaspar and Allan Kaspar are the exiting scientists. Novartis decided to fire them after it learnt that they were involved in manipulation of gene therapy data. The Kaspars scandal The company’s CEO, Vas Narasimhan, […]

Novartis AG (NYSE:NVS) Announces New Clinical Study Updates at the ASCO 2019 Meeting

Novartis AG (NYSE:NVS) posted new clinical study updates in NSCLC at the recently held ASCO 2019 Annual Meeting. This comprised primary efficacy data from the GEOMETRY mono-1 Phase 2 clinical study. It showed that INC280 comes as a potential treatment alternative for subjects with metastatic or locally advanced NSCLC that has MET exon-14 skipping mutation. […]

Sign Up To Get Our Latest Stocks Alerts